Cypress gets OK for cough-cold medications Zutripro, Rezira
MADISON, Miss. — The Food and Drug Administration has approved two cough-cold medications made by Cypress Pharmaceutical, the company said Monday.
Cypress announced the approval of Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride) and Rezira (hydrocodone bitartrate and pseudoephedrine). Both drugs are oral solutions and, because they contain the opioid hydrocodone, are classified as schedule III controlled substances by the Drug Enforcement Administration. Cypress subsidiary Hawthorn Pharmaceuticals will market the drugs.
“Currently, there are very few prescription products for patients suffering from cough and the symptoms associated with the common cold,” Hawthorn EVP sales Chris Smith said.
Cypress said the drugs are the only FDA-approved hydrocodone cough-cold combinations containing a nasal decongestant and that the approval marked the first time the FDA approved new hydrocodone cough medications since 1990.
Men’s Health Network, Abbott underscore health issues through T-Talk Tune-Up campaign
NEW YORK — A new survey indicated that almost 70% of men have an easier time taking care of their cars than their own health.
The survey of 501 men ages 45 to 65 years, which was commissioned by the Men’s Health Network and drug maker Abbott, also found that more than 40% would be more likely to address car issues than health issues, while 28% don’t visit the doctor regularly, and 56% said they were more worried about their spouse’s health than their own.
The survey is part of the T-Talk Tune-Up campaign, launched by the Men’s Health Network and Abbott, to raise awareness of men’s health issues, led by racing champion Terry Labonte and health expert Harry Fisch.
“For many men, tuning up our cars is easier than getting checkups for our health,” Labonte said. “With the help of my wife, Kim, I began to think about my body and my health in the same way I think about the care of my cars. As a result, I scheduled a doctor’s appointment and a series of tests to help stay on top of my health.”
GMA-sponsored NACDS Marketplace seminar will highlight food partnership opportunities
WASHINGTON — The Grocery Manufacturers Association and the National Association of Chain Drug Stores will host a seminar aimed at enhancing collaboration between food and consumer product manufacturers and retailers in the drug channel during the upcoming NACDS Marketplace Conference, the associations announced on Monday.
The seminar, which will be held on June 26, in conjunction with the NACDS Marketplace Conference in Boston, will be open to all NACDS Marketplace Conference attendees. It will be held in the Westin Boston Waterfront Hotel, at 425 Summer St., in Grand Ballrooms C and D, beginning at 8 a.m.
The seminar will showcase trading partner collaboration strategies and model practices, with the goal of serving consumers — especially those in "food deserts," which refers to geographic areas that lack food stores. Nielsen SVP consumer and shopper insights Todd Hale will deliver keynote remarks about how food products are performing in drug and dollar channels.
Hale will be followed by two panel discussions. The first panel will focus on the products, services and other tools that trading partners are offering to help consumers pursue healthier lifestyles. The second panel will assess the broader landscape of trading partner collaboration opportunities to assist shoppers as they look to drug and other small-format stores for food purchases.
Seminar participants include representatives of General Mills, Hershey, Kraft Foods, Navarro Discount Pharmacy, Rite Aid and Unilever.